COVID-19 Impact On Genito-Urinary Drugs Market 2020-2030: Future Development, Top Manufacturers, Trends, Share, Size and Forecast

The Business Research Company offers " Genito-Urinary Drugs Global Market Report 2020-30: COVID-19 Impact And Recovery" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global genito-urinary drugs market is expected to decline from $54.2 billion in 2019 to $43.8 billion in 2020 at a compound annual growth rate (CAGR) of -19.3%. The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread. Currently there is less demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 4% from 2021 and reach $61.4 billion in 2023.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3144

The genito-urinary drugs market consists of sales of genito-urinary drugs and related services by entities (organizations, sole traders and partnerships) that produce genito-urinary drugs to treat genito- urinary diseases. This industry includes establishments that produce infertility drugs, hormonal contraceptives, erectile dysfunction drugs and hormonal replacement drugs to treat infertility, infections and prevent pregnancy. It also consists of establishments which produce drugs for benign prostatic hypertrophy, drugs for urinary incontinence and overactive bladder, diuretics to treat urinary calculi, cystic kidney disease, Reno vascular diseases, glomerular disorders and other urinary disorders.

The launch of combination products for the treatment of urinary tract infections is an emerging trend in the genito-urinary disorder drugs market. Competitors in the market are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genito-urinary disorders. For instance, Merck Sharp & Dohme Corp. offers ZERBAXA, a combination drug of a novel cephalosporin and a beta-lactamase inhibitor used for the treatment of complicated urinary tract infections.
Genito-Urinary Drugs Market Segmentation: -
By Type
Hormonal Contraceptives
Drugs For Benign Prostatic hypertrophy
Drugs For Infertility
Drugs For Erectile Dysfunction
Drugs For Urinary Incontinence And Overactive Bladder
Drugs For Infections And Others
Drugs For Hormonal Replacement Therapy
Diuretics

By Distribution Channel
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Others

By Route Of Administration
Oral
Parenteral
Others

By Drug Classification
Branded Drugs
Generic Drugs

By Mode Of Purchase
Prescription-Based Drugs
Over-The-Counter Drugs

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report-2020-30-covid-19-impact-and-recovery

Few Points From Table Of Content
1. Executive Summary
2. Report Structure
3. Genito-Urinary Drugs Market Characteristics
4. Genito-Urinary Drugs Market Product Analysis
5. Genito-Urinary Drugs Market Supply Chain
......
20. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer

The report covers the trends and market dynamics of the Genito-Urinary Drugs Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3144&type=smp

Some of the key players involved in the Genito-Urinary Drugs Market are Daiichi Sankyo Company; Pfizer Inc; Bayer AG; Astellas Pharma Inc; Allergan Plc

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.